Crown Prince Mohammed bin Salman arrives in the U.S. for the first time since 2018, focusing on enhancing economic and defense ties with President Trump amidst ongoing Middle Eastern tensions.
A small faction of Senate Democrats has struck a controversial deal with Republicans to end the government shutdown, revealing deep divisions within the party. Tune in as Catie Edmondson and Shane Goldmacher dissect the implications of this unexpected agreement.
In a decisive 60-40 vote, the Senate has passed a bill to reopen the government after the longest shutdown in U.S. history. This bipartisan agreement includes crucial funding measures but excludes ACA subsidy extensions, raising concerns about rising health care costs.
Countries are gathering at COP30 in Brazil to discuss climate change, but a new UN report reveals that global efforts are lagging behind. With the U.S. pulling back, what does this mean for our planet's future?
The Senate is gearing up for a crucial vote aimed at ending the government shutdown, with both parties exploring new strategies. Will they finally reach a bipartisan agreement to protect federal workers?
Eli Lilly & Co. and Novo Nordisk A/S have struck a deal with the Trump administration to lower prices for their popular weight-loss drugs, Zepbound and Wegovy, while gaining tariff relief and expanding Medicare access. This agreement aims to increase availability for older Americans.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.
In a groundbreaking move, President Trump announces deals with Eli Lilly and Novo Nordisk to reduce obesity drug prices, making treatments more accessible for millions of Americans. Medicare coverage for GLP-1 drugs starts in 2026, changing the landscape of obesity treatment.
In a bold move, Pfizer has filed a lawsuit against Novo Nordisk and Metsera, claiming their merger violates antitrust laws and threatens competition in the obesity drug market.
With over 40 million Americans at risk of losing vital SNAP benefits due to the ongoing government shutdown, Treasury Secretary Scott Bessent hints at possible emergency payouts by Wednesday. However, uncertainty remains as federal courts mandate action on funding.